Cagrilintide 5mg
$95.00
Cagrilintide is a long-acting analog of amylin, a natural peptide released alongside insulin. Animal studies have shown its potential as a treatment for obesity and type 2 diabetes. Beyond diabetes, cagrilintide has been investigated for possible benefits in liver damage, alcohol-related liver disease, and cardiovascular disease. Although some speculate about its role in Alzheimer's disease, no research has yet been published in this area. Numerous trials, however, have explored the combination of cagrilintide and semaglutide for obesity and type 2 diabetes, where the two peptides seem to work synergistically, offering more substantial and lasting weight loss results.